New drug combo trial offers hope for Tough-to-Treat kidney cancer
NCT ID NCT04586231
Summary
This study is testing whether a new combination of two drugs (belzutifan plus lenvatinib) works better than an existing drug (cabozantinib) for people with advanced kidney cancer that has continued to grow despite prior immunotherapy. The main goals are to see which treatment helps patients live longer without their cancer getting worse and which has fewer serious side effects. The trial involves 747 adults whose cancer has spread and who have already tried a specific type of immunotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, RENAL CELL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ATTIKON GENERAL UNIVERSITY HOSPITAL ( Site 3301)
Chaïdári, Attica, 124 62, Greece
-
Aberdeen Royal Infirmary-Department of Oncology ( Site 3105)
Aberdeen, Aberdeen City, AB25 2ZN, United Kingdom
-
AdventHealth Orlando-AdventHealth Medical Group Hematology & Oncology at Orlando ( Site 0003)
Orlando, Florida, 32804, United States
-
Alexandra General Hospital of Athens-ONCOLOGY DEPT. ( Site 3304)
Athens, Attica, 115 28, Greece
-
Amphia Hospital Location Molengracht ( Site 1912)
Breda, North Brabant, 4818 CK, Netherlands
-
Antoni van Leeuwenhoek Ziekenhuis ( Site 1901)
Amsterdam, North Holland, 1066 CX, Netherlands
-
Asan Medical Center ( Site 4200)
Seoul, 05505, South Korea
-
Asociación de Beneficencia Hospital Sirio Libanés ( Site 0804)
Buenos Aires, C1419AHN, Argentina
-
Athens Medical Center ( Site 3303)
Athens, Attica, 151 25, Greece
-
Azienda Ospedaliera Policlinico di Bari ( Site 1402)
Bari, 70124, Italy
-
Azienda Ospedaliera S. Maria di Terni ( Site 1401)
Terni, 05100, Italy
-
BC Cancer Vancouver-Clinical Trials Unit ( Site 0110)
Vancouver, British Columbia, V5Z 4E6, Canada
-
BP - A Beneficencia Portuguesa de São Paulo-Medical Oncology ( Site 0311)
São Paulo, 01321-001, Brazil
-
Blue Ridge Cancer Care - Roanoke ( Site 0043)
Roanoke, Virginia, 24014, United States
-
Bradfordhill-Clinical Area ( Site 0400)
Santiago, Region M. de Santiago, 8420383, Chile
-
CHU de Bordeaux- Hopital Saint Andre ( Site 1209)
Bordeaux, Gironde, 33075, France
-
CHU de Liege ( Site 1102)
Liège, 4000, Belgium
-
CISSS de la Monteregie-Centre ( Site 0103)
Greenfield Park, Quebec, J4V 2H1, Canada
-
CIUSSS de l Estrie - CHUS - Centre Hosp. Univ. Sherbrooke ( Site 0102)
Sherbrooke, Quebec, J1H 5N4, Canada
-
Cancer & Hematology Centers of Western Michigan ( Site 0018)
Grand Rapids, Michigan, 49503, United States
-
Cancer Partners of Nebraska ( Site 0086)
Lincoln, Nebraska, 68510, United States
-
Cedars Sinai Medical Center ( Site 0027)
Los Angeles, California, 90048, United States
-
Centre Antoine Lacassagne ( Site 1217)
Nice, Alpes-Maritimes, 06189, France
-
Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0
Québec, Quebec, G1J 1Z4, Canada
-
Centro Gaucho Integrado de Oncologia ( Site 0304)
Porto Alegre, Rio Grande do Sul, 90110-270, Brazil
-
Centro de Urología (CDU) ( Site 0803)
CABA, Buenos Aires, C1120AAT, Argentina
-
Centrul de Oncologie "Sfântul Nectarie" ( Site 2502)
Craiova, Dolj, 200542, Romania
-
Centrum Onkologii im. Prof. Franciszka Lukaszczyka ( Site 2402)
Bydgoszcz, Kuyavian-Pomeranian Voivodeship, 85-796, Poland
-
Charite Universitaetsmedizin Berlin ( Site 1321)
Berlin, 10117, Germany
-
Chonnam National University Hwasun Hospital-Oncology ( Site 4203)
Hwasun, Jeonranamdo, 58128, South Korea
-
Clinique Francois Chenieux ( Site 1210)
Limoges, Haute-Vienne, 87039, France
-
Cliniques Universitaires Saint Luc - Bruxelles ( Site 1105)
Brussels, Bruxelles-Capitale, Region de, 1200, Belgium
-
Complejo Hospitalario Universitario A Coruna ( Site 1502)
A Coruña, La Coruna, 15006, Spain
-
Confluence Health | Wenatchee Valley Hospital & Clinics ( Site 0061)
Wenatchee, Washington, 98801, United States
-
Cross Cancer Institute ( Site 0111)
Edmonton, Alberta, T6G 1Z2, Canada
-
Duke Cancer Institute ( Site 0096)
Durham, North Carolina, 27710, United States
-
Emory University Hospital ( Site 0012)
Atlanta, Georgia, 30322, United States
-
Erasmus MC ( Site 1913)
Rotterdam, South Holland, GD 3015, Netherlands
-
European Interbalkan Medical Center-Oncology Department ( Site 3300)
Thessaloniki, 570 01, Greece
-
FSBI United Hospital with Polyclinic ( Site 2613)
Moscow, Moscow, 119285, Russia
-
Fakultni Thomayerova nemocnice-Onkologicka klinika 1. LF UK ( Site 2200)
Prague, Praha 4, 140 59, Czechia
-
Fakultni nemocnice Hradec Kralove-Klinika onkologie a radioterapie ( Site 2201)
Hradec Králové, 500 05, Czechia
-
Fakultni nemocnice v Motole-Onkologicka klinika 2. LF UK a FN Motol ( Site 2205)
Prague, Praha 5, 150 06, Czechia
-
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 1400)
Milan, 20133, Italy
-
Fondazione Policlinico Universitario Agostino Gemelli-Medical Oncology ( Site 1410)
Roma, 00168, Italy
-
Franciscus Gasthuis & Vlietland, Locatie Vlietland ( Site 1909)
Schiedam, South Holland, 3118 JH, Netherlands
-
Fujita Health University ( Site 5003)
Toyoake, Aichi-ken, 470-1192, Japan
-
Fundación Cardiovascular de Colombia ( Site 0501)
Piedecuesta, Santander Department, 681017, Colombia
-
Fundación Colombiana de Cancerología Clínica Vida ( Site 0505)
Medellín, Antioquia, 050030, Colombia
-
GenesisCare North Shore ( Site 4011)
St Leonards, New South Wales, 2065, Australia
-
Georgetown University Medical Center ( Site 0006)
Washington D.C., District of Columbia, 20007, United States
-
Grand Hopital de Charleroi ( Site 1104)
Charleroi, Hainaut, 6000, Belgium
-
HELIOS Klinikum Berlin-Buch ( Site 1311)
Berlin, 13125, Germany
-
HYKS ( Site 1800)
Helsinki, Uusimaa, 00290, Finland
-
Hadassah Medical-Oncology department ( Site 2609)
Moscow, Moscow Oblast, 121205, Russia
-
Haga Ziekenhuis locatie Leyweg-Oncology ( Site 1917)
The Hague, South Holland, 2545 AA, Netherlands
-
Hamamatsu University School of Medicine University Hospital ( Site 5004)
Hamamatsu, Shizuoka, 431-3192, Japan
-
Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0114)
Hamilton, Ontario, L8V 5C2, Canada
-
HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0005)
Saint Louis Park, Minnesota, 55426, United States
-
Helios Klinikum Erfurt GmbH ( Site 1315)
Erfurt, Thuringia, 99089, Germany
-
Hopital Tenon ( Site 1213)
Paris, 75020, France
-
Hopitaux Universitaires de Geneve HUG ( Site 1602)
Geneva, Canton of Geneva, 1211, Switzerland
-
Hospital Británico de Buenos Aires-Oncology ( Site 0801)
Ciudad Autónoma de Buenos Aires, Buenos Aires, 1280, Argentina
-
Hospital Clinic i Provincial ( Site 1500)
Barcelona, 08036, Spain
-
Hospital Clinico San Carlos ( Site 1504)
Madrid, 28040, Spain
-
Hospital General Universitario Gregorio Maranon ( Site 1505)
Madrid, 28009, Spain
-
Hospital Paulistano - Amil Clinical Research ( Site 0308)
São Paulo, 01321-001, Brazil
-
Hospital Santa Creu i Sant Pau ( Site 1501)
Barcelona, 08041, Spain
-
Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 1507)
Barcelona, 08035, Spain
-
Hospital Universitario 12 de Octubre-Medical Oncology ( Site 1508)
Madrid, Madrid, Comunidad de, 28041, Spain
-
Hospital Virgen del Rocio ( Site 1503)
Seville, 41013, Spain
-
Huntsman Cancer Institute-HCI Clinical Trials Office ( Site 7001)
Salt Lake City, Utah, 84112-5500, United States
-
IRCCS Ospedale San Raffaele ( Site 1409)
Milan, 20132, Italy
-
Illinois Cancer Care, PC ( Site 0008)
Peoria, Illinois, 61615, United States
-
Imperial Healthcare NHS Trust Charing Cross Hospital ( Site 3107)
London, London, City of, W6 8RF, United Kingdom
-
Institut Claudius Regaud ( Site 1215)
Toulouse, Haute-Garonne, 31059, France
-
Institut Jean Godinot ( Site 1216)
Reims, Ain, 51726, France
-
Institut Jules Bordet ( Site 1103)
Anderlecht, Bruxelles-Capitale, Region de, 1070, Belgium
-
Institut de Cancerologie de l Ouest Centre Rene Gauducheau ( Site 1201)
Saint-Herblain, Loire-Atlantique, 44805, France
-
Institut de Cancerologie de l Ouest Site Paul Papin ( Site 1200)
Angers, Maine-et-Loire, 49055, France
-
Institut de cancérologie Strasbourg Europe (ICANS) ( Site 1218)
Strasbourg, Alsace, 67200, France
-
Instituto Alexander Fleming ( Site 0800)
Ciudad Autónoma de Buenos Aires, Buenos Aires, C1426ANZ, Argentina
-
Instituto Nacional de Cancerología-Clinical Oncology ( Site 0500)
Bogotá, Cundinamarca, 111511, Colombia
-
Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 2500)
Cluj-Napoca, Cluj, 400015, Romania
-
Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 2501)
Cluj-Napoca, Cluj, 400015, Romania
-
Ironwood Cancer & Research Centers ( Site 0077)
Chandler, Arizona, 85224, United States
-
Istituti Clinici Scientifici Maugeri Spa ( Site 1403)
Pavia, 27100, Italy
-
Istituto Clinico Humanitas Research Hospital ( Site 1406)
Rozzano, Milano, 20089, Italy
-
Istituto Oncologica della Svizzera Italiana (IOSI) ( Site 1604)
Bellinzona, Canton Ticino, 6500, Switzerland
-
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori ( Site 1407)
Meldola, Forli-Cesena, 47014, Italy
-
Ivanovo Regional Oncology Dispensary ( Site 2616)
Ivanovo, Ivanovo Oblast, 153040, Russia
-
James Lind Centro de Investigación del Cáncer ( Site 0402)
Temuco, Región de la Araucanía, 4780000, Chile
-
Kantonsspital Graubuenden ( Site 1600)
Chur, Kanton Graubünden, 7000, Switzerland
-
Keio university hospital ( Site 5011)
Tokyo, 160-8582, Japan
-
Kindai University Hospital- Osakasayama Campus-Urology ( Site 5010)
Sayama, Osaka, 589-8511, Japan
-
Kingston Health Sciences Centre ( Site 0105)
Kingston, Ontario, K7L 2V7, Canada
-
Klinik Ottakring-1.Medizinische Abteilung - Zentrum für Onkologie und Hämatologie ( Site 1031)
Vienna, Vienna, 1160, Austria
-
Klinik fuer Urologie ( Site 1303)
Freiburg im Breisgau, Baden-Wurttemberg, 79106, Germany
-
Klinikum Nuernberg Nord ( Site 1300)
Nuremberg, Bavaria, 90419, Germany
-
Kobe City Medical Center General Hospital ( Site 5017)
Kobe, Hyōgo, 650-0047, Japan
-
Krankenhaus Martha Maria Halle-Doelau ( Site 1314)
Halle, Saxony-Anhalt, 06120, Germany
-
Krankenhaus der Barmherzigen Brüder Wien ( Site 1041)
Vienna, 1020, Austria
-
Kyushu University Hospital ( Site 5005)
Fukuoka, 812-8582, Japan
-
Lahey Hospital & Medical Center ( Site 0090)
Burlington, Massachusetts, 01805, United States
-
Lehigh Valley Hospital- Cedar Crest-Oncology Clinical Trials ( Site 0056)
Allentown, Pennsylvania, 18103, United States
-
Levine Cancer Institute ( Site 0004)
Charlotte, North Carolina, 28204, United States
-
Liga Norte Riograndense Contra o Cancer ( Site 0313)
Natal, Rio Grande do Norte, 59151600, Brazil
-
Lyell McEwin Hospital ( Site 4004)
Elizabeth Vale, South Australia, 5112, Australia
-
MEDSI Clinical Hospital on Pyatnitsky Highway-Departmentof Antitumor Drug therapy ( Site 2618)
Krasnogorsk, Moscow Oblast, 143442, Russia
-
Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 2203)
Brno, Brno-mesto, 656 53, Czechia
-
Mater Misericordiae University Hospital ( Site 3201)
Dublin, Dublin, D07 R2WY, Ireland
-
Mater Private Hospital - Dublin ( Site 3202)
Dublin, Dublin 7, Ireland
-
Medical Oncology Ospedale San Donato ( Site 1404)
Arezzo, 52100, Italy
-
Medisch Centrum Leeuwarden ( Site 1905)
Leeuwarden, Provincie Friesland, 8934 AD, Netherlands
-
Medizinische Universität Wien ( Site 1021)
Vienna, 1090, Austria
-
Medizinische Universitätsklinik Graz ( Site 1051)
Graz, Styria, 8036, Austria
-
Memorial Sloan Kettering Cancer Center ( Site 0055)
New York, New York, 10065, United States
-
Mount Vernon Cancer Centre ( Site 3101)
Northwood, London, City of, HA6 2RN, United Kingdom
-
Musgrove Park Hospital ( Site 3103)
Taunton, Somerset, TA1 5DA, United Kingdom
-
NCT-Department of Medical Oncology ( Site 1320)
Heidelberg, Baden-Wurttemberg, 69120, Germany
-
Nara Medical University Hospital ( Site 5002)
Kashihara, Nara, 634-8522, Japan
-
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie ( Site 2400)
Warsaw, Masovian Voivodeship, 02-781, Poland
-
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - O-Klinika Onkologii Klinicznej ( Site 240
Krakow, Lesser Poland Voivodeship, 31-115, Poland
-
National Cancer Center Hospital East ( Site 5000)
Kashiwa, Chiba, 2778577, Japan
-
Nemocnice České Budějovice-Onkologicke oddeleni ( Site 2204)
České Budějovice, Jihočeský kraj, 370 01, Czechia
-
Niigata University Medical & Dental Hospital ( Site 5013)
Niigata, 951-8520, Japan
-
Nippon Medical School Hospital ( Site 5006)
Tokyo, 113-8603, Japan
-
Norton Cancer Institute - St. Matthews ( Site 0065)
Louisville, Kentucky, 40207, United States
-
Nottingham University Hospitals NHS Trust. City Hospital Campus ( Site 3106)
Nottingham, England, NG5 1PF, United Kingdom
-
Ordensklinikum Linz GmbH Elisabethinen-Urologie ( Site 1001)
Linz, Upper Austria, 4020, Austria
-
Orlando Health, Inc. ( Site 0035)
Orlando, Florida, 32806, United States
-
Osaka International Cancer Institute ( Site 5016)
Osaka, 541-8567, Japan
-
Osaka University Hospital ( Site 5012)
Suita, Osaka, 565-0871, Japan
-
Ospedale Maggiore Borgo Trento ( Site 1408)
Verona, 37126, Italy
-
Ospedale San Luigi Gonzaga ( Site 1405)
Orbassano, Torino, 10043, Italy
-
Parkview Cancer Institute ( Site 0088)
Fort Wayne, Indiana, 46845, United States
-
Peninsula Health Frankston Hospital ( Site 4001)
Frankston, Victoria, 3199, Australia
-
Peter MacCallum Cancer Centre-Parkville Cancer Clinical Trials Unit (PCCTU) ( Site 4010)
Melbourne, Victoria, 3000, Australia
-
Providence Saint John's Health Center ( Site 0083)
Santa Monica, California, 90404, United States
-
R.J. Zuckerberg Cancer Center-Medical Oncology ( Site 0013)
Lake Success, New York, 11042, United States
-
Royal United Hospital Bath England ( Site 3108)
Bath, Bath And North East Somerset, BA1 3NG, United Kingdom
-
Rush University Medical Center ( Site 0040)
Chicago, Illinois, 60607, United States
-
Rutgers Cancer Institute of New Jersey ( Site 0078)
New Brunswick, New Jersey, 08901, United States
-
SHI of Moscow City Oncology Clinical Hospital - 62 ( Site 2614)
Moscow, Moscow, 125130, Russia
-
Samsung Medical Center ( Site 4201)
Seoul, 06351, South Korea
-
Sanatorio Británico-Clinical Oncology Department ( Site 0802)
Rosario, Santa Fe Province, 2000, Argentina
-
Sanatorio Parque ( Site 0806)
Rosario, Santa Fe Province, S2000DSV, Argentina
-
Sapporo Medical University Hospital ( Site 5008)
Sapporo, Hokkaido, 060-8543, Japan
-
Seattle Cancer Care Alliance-Renal/Melanoma/MCC ( Site 0093)
Seattle, Washington, 98109, United States
-
Singleton Hospital ( Site 3111)
Swansea, Wales, SA2 8QA, United Kingdom
-
Sociedad De Oncologia Y Hematologia Del Cesar-Oncology ( Site 0508)
Valledupar, Cesar Department, 200001, Colombia
-
Southend University Hospital ( Site 3112)
Southend, Essex, SS0 0RY, United Kingdom
-
St. Joseph Hospital-The Center for Cancer Prevention and Treatment ( Site 0095)
Orange, California, 92868, United States
-
Sunnybrook Health Sciences - Odette Cancer Centre ( Site 0113)
Toronto, Ontario, M4N 3M5, Canada
-
TYKS ( Site 1802)
Turku, Southwest Finland, 20520, Finland
-
Tallaght University Hospital ( Site 3200)
Dublin, D24NR0A, Ireland
-
Tampereen yliopistollinen sairaala ( Site 1801)
Tampere, Pirkanmaa, 33520, Finland
-
The Moncton Hospital ( Site 0101)
Moncton, New Brunswick, E1C 6Z8, Canada
-
The Ottawa Hospital - General Campus-The Ottawa Hospital Cancer Centre ( Site 0116)
Ottawa, Ontario, K1H 8L6, Canada
-
Toho University Sakura Medical Center ( Site 5014)
Sakura, Chiba, 285-8741, Japan
-
Tokyo Medical and Dental University Hospital ( Site 5009)
Bunkyo-ku, Tokyo, 1138519, Japan
-
Tokyo Women's Medical University Adachi Medical Center ( Site 5015)
Tokyo, 123-8558, Japan
-
Tom Baker Cancer Centre ( Site 0109)
Calgary, Alberta, T2N 4N2, Canada
-
Toranomon Hospital ( Site 5001)
Minato-ku, Tokyo, 105-8470, Japan
-
Tulane University School of Medicine ( Site 0098)
New Orleans, Louisiana, 70112, United States
-
UC Irvine Health ( Site 0029)
Orange, California, 92868, United States
-
UCLA Hematology/Oncology - Santa Monica ( Site 0048)
Los Angeles, California, 90404, United States
-
UNIVERSITY HOSPITAL OF PATRAS-DIVISION OF ONCOLOGY ( Site 3302)
Pátrai, Achaia, 26504, Greece
-
UZ Gent ( Site 1100)
Ghent, Oost-Vlaanderen, 9000, Belgium
-
UZ Leuven ( Site 1101)
Leuven, Vlaams-Brabant, 3000, Belgium
-
Universitaetsklinikum Aachen AOER ( Site 1317)
Aachen, North Rhine-Westphalia, 52074, Germany
-
Universitaetsklinikum Frankfurt ( Site 1301)
Frankfurt am Main, Hesse, 60590, Germany
-
Universitaetsklinikum des Saarlandes ( Site 1305)
Homburg/ Saar, Saarland, 66421, Germany
-
Universitaetsspital Zuerich ( Site 1601)
Zurich, Canton of Zurich, 8001, Switzerland
-
Universitair Medisch Centrum Utrecht ( Site 1910)
Utrecht, 3584CX, Netherlands
-
University Cancer & Blood Center, LLC ( Site 0057)
Athens, Georgia, 30607, United States
-
University of Mississippi Medical Ctr ( Site 0037)
Jackson, Mississippi, 39213, United States
-
University of Texas, Southwestern Medical Center ( Site 0015)
Dallas, Texas, 75390-7208, United States
-
University of Vermont Medical Center ( Site 0001)
Burlington, Vermont, 05401, United States
-
Uniwersytecki Szpital Kliniczny w Poznaniu ( Site 2401)
Poznan, Greater Poland Voivodeship, 60-569, Poland
-
Volgograd Regional Uronephrological Center ( Site 2615)
Volzhsky, Volgograd Oblast, 404120, Russia
-
Yaroslavl Regional Cancer Hospital-Oncology ( Site 2619)
Yaroslavl, Yaroslavl Oblast, 150054, Russia
-
Yokohama City University Hospital ( Site 5007)
Yokohama, Kanagawa, 2360004, Japan
-
Zuyderland Medical Centre-Trialbureau Interne Geneeskunde ( Site 1904)
Sittard-Geleen, Limburg, 6162 BG, Netherlands
Conditions
Explore the condition pages connected to this study.